Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:2017:5415298.
doi: 10.1155/2017/5415298. Epub 2017 Oct 30.

Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review

Mohammed Biset Ayalew  1
Affiliations
Review

Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review

Mohammed Biset Ayalew. AIDS Res Treat. 2017.

Abstract

Background: Even though the benefit of antiretroviral therapy (ART) is well established, there is a regional variation in the extent of its benefit. The aim of this review is to highlight mortality and its predictors in Ethiopian adult HIV patients who were on ART.

Methods: Relevant articles were searched on PubMed and Google Scholar databases. The search terms used in different combinations were predictor/determinant/factors, mortality/death/survival, HIV, ART/HAART, and Ethiopia.

Result: 5-40.8% of the patients died during the follow-up period. More than half (50-68.8%) of the deaths occurred within 6 months of initiating ART. Advanced stage disease (stage III and stage IV), nonworking functional status (bedridden and ambulatory), low baseline CD4 count, low baseline hemoglobin level, TB coinfection, lower baseline weight, and poor treatment adherence were commonly identified as predictors of death in HIV patients.

Conclusion: 5-40.8% of HIV patients in Ethiopia die in 2-5 years of initiating antiretroviral treatment. Most of the deaths in HIV patients occur early in the course of treatment. Special emphasis should be given for patients with advanced stage disease, nonworking functional status, low baseline CD4 count, low baseline hemoglobin level, TB coinfection, lower baseline weight, and poor treatment adherence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Article selection process.
See this image and copyright information in PMC

References

    1. UNAIDS. Geneva, Switzerland: UNAIDS; 2013. UNAIDS report on the global AIDS epidemic.
    1. Muhula S. O., Peter M., Sibhatu B., Meshack N., Lennie K. Effects of highly active antiretroviral therapy on the survival of hiv-infected adult patients in urban slums of kenya. Pan African Medical Journal. 2015;20(1) doi: 10.11604/pamj.2015.20.63.486. - DOI - PMC - PubMed
    1. WHO. Geneva, Switzerland: WHO; 2013. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: summary of key features and recommendations.
    1. HAPCOF. Report on progress towards implementation of the UN declaration of commitment on HIV/AIDS. 2010
    1. Sapa W. B., Negassi N. T., Chofore A. H. Survival pattern and its determinants among adult HIV-infected patients after initiation of HAART in Dilla hospital Ethiopia. Journal of AIDS & Clinical Research. 2016;1(1):1–6.

LinkOut - more resources